|
1
|
Sun PC, Uppaluri R, Schmidt AP, Pashia ME,
Quant EC, Sunwoo JB, Gollin SM and Scholnick SB: Transcript map of
the 8p23 putative tumor suppressor region. Genomics. 75:17–25.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lau WL and Scholnick SB: Identification of
two new members of the CSMD gene family. Genomics. 82:412–415.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shimizu A, Asakawa S, Sasaki T, Yamazaki
S, Yamagata H, Kudoh J, Minoshima S, Kondo I and Shimizu N: A novel
giant gene CSMD3 encoding a protein with CUB and sushi multiple
domains: A candidate gene for benign adult familial myoclonic
epilepsy on human chromosome 8q23.3-q24.1. Biochem Biophys Res
Commun. 309:143–154. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kraus DM, Elliott GS, Chute H, Horan T,
Pfenninger KH, Sanford SD, Foster S, Scully S, Welcher AA and
Holers VM: CSMD1 is a novel multiple domain complement-regulatory
protein highly expressed in the central nervous system and
epithelial tissues. J Immunol. 176:4419–4430. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Escudero-Esparza A, Kalchishkova N,
Kurbasic E, Jiang WG and Blom AM: The novel complement inhibitor
human CUB and Sushi multiple domains 1 (CSMD1) protein promotes
factor I-mediated degradation of C4b and C3b and inhibits the
membrane attack complex assembly. FASEB J. 27:5083–5093. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Toomes C, Jackson A, Maguire K, Wood J,
Gollin S, Ishwad C, Paterson I, Prime S, Parkinson K, Bell S, et
al: The presence of multiple regions of homozygous deletion at the
CSMD1 locus in oral squamous cell carcinoma question the role of
CSMD1 in head and neck carcinogenesis. Genes Chromosomes Cancer.
37:132–140. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Macoska JA, Trybus TM, Benson PD, Sakr WA,
Grignon DJ, Wojno KD, Pietruk T and Powell IJ: Evidence for three
tumor suppressor gene loci on chromosome 8p in human prostate
cancer. Cancer Res. 55:5390–5395. 1995.PubMed/NCBI
|
|
8
|
Tørring N, Borre M, Sørensen KD, Andersen
CL, Wiuf C and Ørntoft TF: Genome-wide analysis of allelic
imbalance in prostate cancer using the Affymetrix 50K SNP mapping
array. Br J Cancer. 96:499–506. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Blaveri E, Brewer JL, Roydasgupta R,
Fridlyand J, DeVries S, Koppie T, Pejavar S, Mehta K, Carroll P,
Simko JP, et al: Bladder cancer stage and outcome by array-based
comparative genomic hybridization. Clin Cancer Res. 11:7012–7022.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma C, Quesnelle KM, Sparano A, Rao S, Park
MS, Cohen MA, Wang Y, Samanta M, Kumar MS, Aziz MU, et al:
Characterization of CSMD1 in a large set of primary lung, head and
neck, breast and skin cancer tissues. Cancer Biol Ther. 8:907–916.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Paris PL, Andaya A, Fridlyand J, Jain AN,
Weinberg V, Kowbel D, Brebner JH, Simko J, Watson JE, Volik S, et
al: Whole genome scanning identifies genotypes associated with
recurrence and metastasis in prostate tumors. Hum Mol Genet.
13:1303–1313. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang R and Song C: Loss of CSMD1 or 2 may
contribute to the poor prognosis of colorectal cancer patients.
Tumour Biol. 35:4419–4423. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shull AY, Clendenning ML, Ghoshal-Gupta S,
Farrell CL, Vangapandu HV, Dudas L, Wilkerson BJ and Buckhaults PJ:
Somatic mutations, allele loss, and DNA methylation of the Cub and
Sushi Multiple Domains 1 (CSMD1) gene reveals association with
early age of diagnosis in colorectal cancer patients. PLoS One.
8:e587312013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kamal M, Shaaban AM, Zhang L, Walker C,
Gray S, Thakker N, Toomes C, Speirs V and Bell SM: Loss of CSMD1
expression is associated with high tumour grade and poor survival
in invasive ductal breast carcinoma. Breast Cancer Res Treat.
121:555–563. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang M-R, Wang Y-X, Guo S, Han S-Y and
Wang D: CSMD1 exhibits antitumor activity in A375 melanoma cells
through activation of the Smad pathway. Apoptosis. 17:927–937.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lang M-F, Yang S, Zhao C, Sun G, Murai K,
Wu X, Wang J, Gao H, Brown CE, Liu X, et al: Genome-wide profiling
identified a set of miRNAs that are differentially expressed in
glioblastoma stem cells and normal neural stem cells. PLoS One.
7:e362482012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu Q, Gong L, Wang J, Tu Q, Yao L, Zhang
JR, Han XJ, Zhu SJ, Wang SM, Li YH, et al: miR-10b exerts oncogenic
activity in human hepatocellular carcinoma cells by targeting
expression of CUB and sushi multiple domains 1 (CSMD1). BMC Cancer.
16:8062016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Debnath J, Muthuswamy SK and Brugge JS:
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini
grown in three-dimensional basement membrane cultures. Methods.
30:256–268. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shaw KR, Wrobel CN and Brugge JS: Use of
three-dimensional basement membrane cultures to model
oncogene-induced changes in mammary epithelial morphogenesis. J
Mammary Gland Biol Neoplasia. 9:297–310. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Holliday DL, Hughes S, Shaw JA, Walker RA
and Jones JL: Intrinsic genetic characteristics determine
tumor-modifying capacity of fibroblasts: Matrix metalloproteinase-3
5A/5A genotype enhances breast cancer cell invasion. Breast Cancer
Res. 9:R672007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Scherl-Mostageer M, Sommergruber W,
Abseher R, Hauptmann R, Ambros P and Schweifer N and Schweifer N:
Identification of a novel gene, CDCP1, overexpressed in human
colorectal cancer. Oncogene. 20:4402–4408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Benes CH, Poulogiannis G, Cantley LC and
Soltoff SP: The SRC-associated protein CUB Domain-Containing
Protein-1 regulates adhesion and motility. Oncogene. 31:653–663.
2012.PubMed/NCBI
|
|
23
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kraus DM, Pfenninger KH, Sanford SD and
Holers VM: CSMD1 is expressed as a membrane protein on neuronal
growth cones that colocalizes with F-actin and alpha-3 integrin.
Mol Immunol. 44:1982007. View Article : Google Scholar
|
|
25
|
Ulrich F and Heisenberg C-P: Trafficking
and cell migration. Traffic. 10:811–818. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Scott RE, Tzen CY, Witte MM, Blatti S and
Wang H: Regulation of differentiation, proliferation and cancer
suppressor activity. Int J Dev Biol. 37:67–74. 1993.PubMed/NCBI
|
|
27
|
Ziober BL, Silverman SS Jr and Kramer RH:
Adhesive mechanisms regulating invasion and metastasis in oral
cancer. Crit Rev Oral Biol Med. 12:499–510. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huttenlocher A, Sandborg RR and Horwitz
AF: Adhesion in cell migration. Curr Opin Cell Biol. 7:697–706.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lambrechts A, Van Troys M and Ampe C: The
actin cytoskeleton in normal and pathological cell motility. Int J
Biochem Cell Biol. 36:1890–1909. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Palecek SP, Huttenlocher A, Horwitz AF and
Lauffenburger DA: Physical and biochemical regulation of integrin
release during rear detachment of migrating cells. J Cell Sci.
111:929–940. 1998.PubMed/NCBI
|
|
31
|
Cox EA, Sastry SK and Huttenlocher A:
Integrin-mediated adhesion regulates cell polarity and membrane
protrusion through the Rho family of GTPases. Mol Biol Cell.
12:265–277. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee J, Moon HJ, Lee JM and Joo CK: Smad3
regulates Rho signaling via NET1 in the transforming growth
factor-beta-induced epithelial-mesenchymal transition of human
retinal pigment epithelial cells. J Biol Chem. 285:26618–26627.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Valdembri D, Caswell PT, Anderson KI,
Schwarz JP, König I, Astanina E, Caccavari F, Norman JC, Humphries
MJ, Bussolino F, et al: Neuropilin-1/GIPC1 signaling regulates
alpha5beta1 integrin traffic and function in endothelial cells.
PLoS Biol. 7:e252009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang G, Zhang Y, Kim B, Ge G, Annis DS,
Mosher DF and Greenspan DS: Fibronectin binds and enhances the
activity of bone morphogenetic protein 1. J Biol Chem.
284:25879–25888. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kuznetsova SA, Mahoney DJ, Martin-Manso G,
Ali T, Nentwich HA, Sipes JM, Zeng B, Vogel T, Day AJ and Roberts
DD: TSG-6 binds via its CUB_C domain to the cell-binding domain of
fibronectin and increases fibronectin matrix assembly. Matrix Biol.
27:201–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Debnath J, Walker SJ and Brugge JS: Akt
activation disrupts mammary acinar architecture and enhances
proliferation in an mTOR-dependent manner. J Cell Biol.
163:315–326. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Deevi RK, Cox OT and O'Connor R: Essential
function for PDLIM2 in cell polarization in three-dimensional
cultures by feedback regulation of the β1-integrin-RhoA signaling
axis. Neoplasia. 16:422–431. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Frisch SM and Francis H: Disruption of
epithelial cell-matrix interactions induces apoptosis. J Cell Biol.
124:619–626. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Humphreys RC, Krajewska M, Krnacik S,
Jaeger R, Weiher H, Krajewski S, Reed JC and Rosen JM: Apoptosis in
the terminal endbud of the murine mammary gland: A mechanism of
ductal morphogenesis. Development. 122:4013–4022. 1996.PubMed/NCBI
|
|
40
|
Debnath J, Mills KR, Collins NL, Reginato
MJ, Muthuswamy SK and Brugge JS: The role of apoptosis in creating
and maintaining luminal space within normal and oncogene-expressing
mammary acini. Cell. 111:29–40. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hebner C, Weaver VM and Debnath J:
Modeling morphogenesis and oncogenesis in three-dimensional breast
epithelial cultures. Annu Rev Pathol. 3:313–339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yanochko GM and Eckhart W: Type I
insulin-like growth factor receptor over-expression induces
proliferation and anti-apoptotic signaling in a three-dimensional
culture model of breast epithelial cells. Breast Cancer Res.
8:R182006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Steen VM, Nepal C, Ersland KM, Holdhus R,
Nævdal M, Ratvik SM, Skrede S and Håvik B: Neuropsychological
deficits in mice depleted of the schizophrenia susceptibility gene
CSMD1. PLoS One. 8:e795012013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Boivin D, Bilodeau D and Béliveau R:
Regulation of cytoskeletal functions by Rho small GTP-binding
proteins in normal and cancer cells. Can J Physiol Pharmacol.
74:801–810. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rao KM and Cohen HJ: Actin cytoskeletal
network in aging and cancer. Mutat Res. 256:139–148. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Trump BF, Heatfield BM, Phelps PC,
Sanefuji H and Shamsuddin AK: Cell surface changes in preneoplastic
and neoplastic epithelium. Scan Electron Microsc. 3:43–60.
1980.
|
|
47
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kharitonova MA and Vasiliev JM:
Controlling cell length. Semin Cell Dev Biol. 19:480–484. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Frame MC and Brunton VG: Advances in
Rho-dependent actin regulation and oncogenic transformation. Curr
Opin Genet Dev. 12:36–43. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Alexandrova AY: Evolution of cell
interactions with extracellular matrix during carcinogenesis.
Biochemistry (Mosc). 73:733–741. 2008. View Article : Google Scholar : PubMed/NCBI
|
